Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 2 I, 1997, Pages 600-608

  Park, Sung Hae ^a   Saleh, Dina ^a   Giaid, Adel ^a,b   Michel, René P ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b Medical Research Council of Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN SULFATE; BOSENTAN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LUNG FIBROSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; VASOCONSTRICTION;

EID: 0030755489     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.2.9607123     Document Type: Article

References (37)

1. Crystal, R. G., P. B. Bitterman, S. I. Rennard, A. J. Hance, and B. A. Keogh. 1984. Interstitial lung disease of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N. Engl. J. Med. 310:154-166.
2. Cherniack, R. M., R. G. Crystal, and A. R. Kalica. 1991. Current concepts in idiopathic pulmonary fibrosis: a road map for the future. Am. Rev. Respir. Dis. 143:680-683.
3. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-115.
4. Inoue, A., M. Yanagisawa, S. Kimura, Y. Kasuya, T. Miyauchi, K. Goto, and T. Masaki. 1989. The human endothelin family: three structually and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. U.S.A. 86:2863-2867.
5. Xu, D., N. Emoto, A. Giaid, C. Slaughter, S. Kaw, D. deWit, and M. Yanagisawa. 1994. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485.
6. Barnes, P. J. 1994. Endothelins and pulmonary diseases. J. Appl. Physiol. 77:1051-1059.
7. Hirata, Y., Y. Takagi, Y. Fukuda, and F. Marumo. 1989. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78:225-228.
8. Muldoon, L. L., K. D. Rodlan, M. L. Forsythe, and B. E. Magun. 1989. Stimulation of phosphatidylinositol hydrolysis, diacylglycerol release, and gene expression in response to endothelin, a potent new agonist for fibroblasts and smooth muscle cells. J. Biol. Chem. 264:8529-8536.
9. Takuwa, N., Y. Takuwa, M. Yanagisawa, K. Yamashita, and T. Masaki. 1989. A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J. Biol. Chem. 264:7856-7861.
10. Arai, H., S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi. 1990. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732.
11. Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. 1990. Cloning of cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735.
12. Giaid, A., R. P. Michel, D. J. Stewart, M. Sheppard, B. Corrin, and Q. Hamid. 1993. Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet 341:1550-1554.
13. Uguccioni, M., L. Pulsatelli, B. Grigolo, A. Facchini, L. Fasano, C. Cinti, M. Fabbri, G. Gasbarrini, and R. Meliconi. 1995. Endothelin-1 in idiopathic pulmonary fibrosis. J. Clin. Pathol. 48:330-334.
14. Adamson, I. Y. R., and D. H. Bowden. 1974. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 77:185-198.
15. Clozel, M., V. Breu, G. A. Gray, B. Kalina, B. Löffler, K. Burri, J. Cassal, G. Hirth, M. Müller, W. Neidhart, and H. Ramuz. 1994. Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270:228-235.
16. Hsu, S. M., L. Raine, and H. Fanger. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J. Histochem. Cytochem. 29:577-580.
17. Shinmi, O., S. Kimura, T. Yoshizawa, T. Sawamura, Y. Uchiyama, Y. Sugita, I. Kanazawa, M. Yanagisawa, K. Goto, and T. Masaki. 1989. Presence of endothelin-1 in porcine spinal cord: isolation and sequence determination. Biochem. Biophys. Res. Commun. 162:340-346.
18. Zwikler, M. P., D. Iancu, and R. P. Michel. 1994. Effects of pulmonary fibrosis on the distribution of edema. Morphometric analysis. Am. J. Respir. Crit. Care Med. 149:1276-1285.
19. Jamison, B. M., F. Hu, and R. P. Michel. 1995. Nonspecific endothelin receptor antagonism decreases bronchial artery proliferation in post-obstructive pulmonary vasculopathy (abstract). Clin. Invest. Med. 18(Suppl.):B112.
20. Khalil, N., C. Whitman, L. Zuo, D. Danielpour, and A. Greenberg. 1993. Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J. Clin. Invest. 92:1812-1818.
21. Khalil, N., R. N. O'Connor, K. C. Flanders, and H. Unruh. 1996. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am. J. Respir. Cell Mol. Biol. 14:131-138.
22. Gauldie, J., M. Jordana, and G. Cox. 1993. Cytokines and pulmonary fibrosis. Thorax 48:931-935.
23. Kovacs, E. J., and L. A. DiPietro. 1994. Fibrogenic cytokines and connective tissue production. FASEB J. 8:854-861.
24. Endo, T., Y. Uchida, H. Matsumoto, N. Suzuki, A. Nomura, F. Hirata, and S. Hasegawa. 1992. Regulation of endothelin-1 synthesis in cultured guinea pig airway epithelial cells by various cytokines. Biochem. Biophys. Res. Commun. 186:1594-1599.
25. Saleh, D., K. Furukawa, M. Tsao, A. Maghazachi, B. Corrin, M. Yanagisawa, P. J. Barnes, and A. Giaid. 1997. Elevated expression of endothelin-1 and endothelin converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines. Am. J. Respir. Cell Mol. Biol. 16:187-193.
26. Wang, X., S. A. Douglas, C. Louden, L. M. Vickery-Clark, G. Z. Feuerstein, and E. H. Ohlstein. 1996. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ. Res. 78:322-328.
27. Battistini, B., P. Chailler, P. D'Orléans-Juste, N. Brière, and P. Sirois. 1993. Growth regulatory properties of endothelins. Peptides 14:385-399.
28. Murlas, C. G., A. Gulati, G. Singh, and F. Najmabadi. 1995. Endothelin-1 stimulates proliferation of normal airway epithelial cells. Biochem. Biophys. Res. Commun. 212:953-959.
29. Kumar, R. K., and A. W. J. Lykke. 1995. Messages and handshakes: cellular interactions in pulmonary fibrosis. Pathology 27:18-26.
30. Marini, M., S. Carpi, A. Bellini, F. Patalano, and S. Mattoli. 1996. Endothelin-1 induces increased fibronectin expression in human bronchial epithelial cells. Biochem. Biophys. Res. Commun. 220:896-899.
31. Eddahibi, S., B. Raffestin, M. Clozel, M. Levame, and S. Adnot. 1995. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am. J. Physiol. 268:H828-H835.
32. Chen, S. J., Y. F. Chen, Q. C. Meng, J. Durand, V. S. Dicarlo, and S. Oparil. 1995. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J. Appl. Physiol. 79:2122-2131.
33. Bartholomeusz, B., K. J. Hardy, A. S. Nelson, and P. A. Phillips. 1996. Bosentan ameliorates cyclosporin A-induced hypertension in rats and primates. Hypertension 27:1341-1345.
34. Kiowski, W., G. Sutsch, P. Hunziker, P. Müller, J. Kim, E. Oechslin, R. Schmitt, R. Jones, and O. Bertel. 1995. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346:732-736.
35. Mallat, A., L. Fouassier, A. M. Preaux, C. S. Gal, D. Raufaste, J. Rosenbaum, D. Dhumeaux, C. Jouneaux, P. Mavier, and S. Lotersztajn. 1995. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells: an endothelin B receptor-mediated pathway. J. Clin. Invest. 96:42-49.
36. Lariviere, R., P. Sventek, P. Thibault, and E. L. Schiffrin. 1995. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan. Can. J. Physiol. Pharmacol. 73:390-398.
37. Kaheleh, M. B. 1991. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma: enhanced production and profibrotic action. Arthritis Rheum. 34:978-983.